SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-209858
Filing Date
2017-06-22
Accepted
2017-06-22 08:00:55
Documents
1
Period of Report
2017-06-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d413859d8k.htm 8-K 12613
  Complete submission text file 0001193125-17-209858.txt   13652
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 17924044
SIC: 2834 Pharmaceutical Preparations